Plitidepsin in patients with advanced renal cancer (RCC):: Results of an exploratory phase II trial

被引：0
|
作者：
Climent, Miguel A.
Schoffski, Patrick
Paz-Ares, Luis
Rivera, Fernando
Bezares, Susana
Pico, Cesar
Tabernero, Josep M.
机构：
[1] Inst Valenciano Oncol, Valencia, Spain
[2] Catholic Univ Leuven Hosp, Canc Inst, Louvain, Belgium
[3] Hosp Univ 12 Octubre, Madrid, Spain
[4] Hosp Univ Marques Vadecilla, Santander, Spain
[5] PharmaMar SAU, Madrid, Spain
[6] Hosp Gen Valle Hebron, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [21] Phase II trial of thalidomide for patients with advanced renal cell carcinoma
    Motzer, RJ
    Berg, W
    Ginsberg, M
    Russo, P
    Vuky, J
    Yu, R
    Bacik, J
    Mazumdar, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 302 - 306
  • [22] Gemcitabine: A phase II study in patients with advanced renal cancer
    DeMulder, PHM
    Weissbach, L
    Jakse, G
    Osieka, R
    Blatter, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (05) : 491 - 495
  • [23] Phase 2 results of ABT-869 treatment in patients with advanced renal cell cancer (RCC) after sunitinib failure
    Tannir, N.
    Wong, Y.
    Kollmannsberger, C.
    Ernstoff, M. S.
    Perry, D. J.
    Appleman, L. J.
    Posadas, E.
    Qian, J.
    Ricker, J. L.
    Michaelson, D. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 425 - 425
  • [24] A phase II trial of perifosine in patients with advanced renal cell carcinoma (RCC) who have failed tyrosine kinase inhibitors (TKI)
    Cho, D. C.
    Figlin, R. A.
    Flaherty, K. T.
    Michaelson, D.
    Sosman, J. A.
    Ghebremichael, M.
    Bowers, M. E.
    Mier, J. W.
    Atkins, M. B.
    McDermott, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Phase II trial of linifanib in patients (pts) with advanced renal cell carcinoma (RCC): Analysis of pts receiving extended therapy.
    Posadas, E. M.
    Tannir, N. M.
    Wong, Y.
    Ernstoff, M. S.
    Kollmannsberger, C. K.
    Qian, J.
    Ansell, P. J.
    McKeegan, E. M.
    Mckee, M. D.
    Ricker, J. L.
    Carlson, D. M.
    Michaelson, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Phase II trial of curcumin in patients with advanced pancreatic cancer
    Dhillon, Navneet
    Aggarwal, Bharat B.
    Newman, Robert A.
    Wolff, Robert A.
    Kunnumakkara, Ajaikumar B.
    Abbruzzese, James L.
    Ng, Chaan S.
    Badmaev, Vladimir
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4491 - 4499
  • [27] Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer
    Redman, BG
    Esper, P
    Pan, QT
    Dunn, RL
    Hussain, HK
    Chenevert, T
    Brewer, GJ
    Merajver, SD
    CLINICAL CANCER RESEARCH, 2003, 9 (05) : 1666 - 1672
  • [28] PHASE-II TRIAL OF RETINOL IN PATIENTS WITH ADVANCED CANCER
    GOODMAN, GE
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 1023 - 1024
  • [29] A phase II trial of FUdR in patients with advanced pancreatic cancer
    Bach Ardalan
    Mayra Lima
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 561 - 566
  • [30] A phase II trial of FUdR in patients with advanced pancreatic cancer
    Ardalan, B
    Lima, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (10) : 561 - 566
12345